Skip to main content
NCBI home page
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 2003 Jun;80(2):330–348. doi: 10.1093/jurban/jtg035

Secondary syringe exchange among injection drug users

Judith Snead 1,2, Moher Downing 1,✉, Jennifer Lorvick 1,2, Barbara Garcia 1, Robert Thawley 1,2, Susan Kegeles 1, Brian R Edlin 1
PMCID: PMC3456273  PMID: 12791808

Abstract

Syringe-exchange programs (SEPs) have proven to prevent the spread of bloodborne pathogens, primarily human immunodeficiency virus (HIV), among injection drug users (IDUs). In the United States, only about 7% of IDUs have access to and use SEPs. Some IDUs engage in secondary syringe exchange (SSE), meaning that one IDU (a “provider”) obtains syringes at an SEP to distribute to other IDUs (“recipients”). This formative qualitative research was conducted to understand why and how IDUs engage in SSE to aid in the development of a large-scale peer HIV prevention intervention. Interviews with 47 IDUs in Oakland and Richmond, California, indicated that SSE was embedded in existing social networks, which provided natural opportunities for peer education. SSE providers reported a desire to help other IDUs as their primary motivation, while recipients reported convenience as their primary reason for using SSE. Building SSE into SEP structures can facilitate an effective provision of risk reduction supplies and information to IDUs who do not access SEPs directly.

Keywords: HIV prevention, Injection drug use, Peer intervention, Secondary syringe exchange, Social networks

Full Text

The Full Text of this article is available as a PDF (108.5 KB).

References

  • 1.Normand J, Vlahov D, Moses LE. Preventing HIV Transmission: the Role of Sterile Needles and Bleach. Washington, DC: National Academy Press; 1995. [PubMed] [Google Scholar]
  • 2.National Institutes of Health. Interventions to prevent HIV risk behaviors NIH Consensus Statement. 1997;15:1–41. [PubMed] [Google Scholar]
  • 3.Lurie P, Reingold AL, editors. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. Vol. 1. San Francisco, CA: University of California; 1993. [Google Scholar]
  • 4.Kral AH, Bluthenthal RN, Lorvick J, Bacchetti P, Gee L, Edlin BR. Effect of syringe exchange utilization on a cohort of syringe sharing IDUs in San Francisco, 1989–1998. In: Proceedings of 127th meeting of the American Public Health Association; November 7–11, 1999; Chicago, IL.
  • 5.Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA. 1994;271:115–120. doi: 10.1001/jama.271.2.115. [DOI] [PubMed] [Google Scholar]
  • 6.Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS. 2000;14:605–611. doi: 10.1097/00002030-200003310-00015. [DOI] [PubMed] [Google Scholar]
  • 7.Schoenbaum EE, Hartel DM, Gourevitch MN. Needle exchange use among a cohort of injecting drug users. AIDS. 1996;10:1729–1734. doi: 10.1097/00002030-199612000-00018. [DOI] [PubMed] [Google Scholar]
  • 8.Hart GJ, Carvell ALM, Woodward N, Johnson AM, Williams P, Parry JV. Evaluation of needles in central London: behavior change and anti-HIV status over one year. AIDS. 1989;3:261–265. [PubMed] [Google Scholar]
  • 9.Hartgers C, Buning EC, Santen GW, Verster AD, Coutinho RA. The impact of the needle and syringe exchange programme in Amsterdam in injecting risk behavior. AIDS. 1989;3:571–576. doi: 10.1097/00002030-198909000-00003. [DOI] [PubMed] [Google Scholar]
  • 10.Hoek JA, Haastrecht HJ, Coutinho RA. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health. 1989;10:1355–1357. doi: 10.2105/ajph.79.10.1355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bluthenthal RN, Kral AH, Erringer EA, Edlin BR. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992–1995. J. Acquir Immune Defic Syndr. 1998;18:505–511. doi: 10.1097/00042560-199808150-00013. [DOI] [PubMed] [Google Scholar]
  • 12.Paone D, Caloir S, Shi Q, Jarlais DC. Sex, drugs and syringe exchange in New York City: women’s experience. J Am Med Womens Assoc. 1995;50:109–114. [PubMed] [Google Scholar]
  • 13.Kipke MD, Edgington R, Unger J, Palmer R. An evaluation of IDU and needle exchange services for street youth. In: Proceedings of 123rd American Public Health Association Meeting; October 29-November 2, 1995; San Diego, CA.
  • 14.Perlis TE, Friedman SR, Des Jarlais DC, Rockwell R. Predictors of indirect sharing among IDUs. In; Proceedings of 124th American Public Health Association Meeting. November 17–21, 1996; New York, NY.
  • 15.Kaplan EH. A method for evaluating needle exchange programmes. Stat Med. 1994;13:2179–2187. doi: 10.1002/sim.4780131923. [DOI] [PubMed] [Google Scholar]
  • 16.Hagan H, Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health. 1995;85:1531–1537. doi: 10.2105/ajph.85.11.1531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Des Jarlais DC, Hagan, H, Paone D, Friedman SR. HIV incidence among syringe exchange participants: the international data. In: Proceedings of 11th International Conference on AIDS; July 7–12, 1996; Vancouver, British Columbia, Canada.
  • 18.Brooner R, Kidorf M, King V, Beilenson P, Svikis D, Vlahov D. Drug abuse treatment success among needle exchange participants. Public Health Rep. 1998;113(Suppl 1):129–139. [PMC free article] [PubMed] [Google Scholar]
  • 19.Hagan H, Jarlais DC, Purchase D, Ried T, Friedmand SR. The Tacoma syringe exchange. J Addict Disease. 1991;10:81–88. doi: 10.1300/J069v10n04_06. [DOI] [PubMed] [Google Scholar]
  • 20.Strathdee SA, Celentano DD, Shah N, et al. Needle exchange attendance and health care utilization promote entry into detoxification. J Urban Health. 1999;76:448–460. doi: 10.1007/BF02351502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Drucker E, Lurie P, Wodak A, Alcabes P. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS. 1998;12(suppl A):S217–S230. [PubMed] [Google Scholar]
  • 22.Strathdee SA, Vlahov D. The effectiveness of needle exchange programs: a review of the science and policy. AID Science. December 2001. Available at: http://aidscience.org/Articles/aidscience013.asp.
  • 23.Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:F59–F65. doi: 10.1097/00002030-199708000-00001. [DOI] [PubMed] [Google Scholar]
  • 24.Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol. 1997;146:994–1002. doi: 10.1093/oxfordjournals.aje.a009792. [DOI] [PubMed] [Google Scholar]
  • 25.Hurley SF, Jolley DJ, Kaldor JM. Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet. 1997;349:1797–1800. doi: 10.1016/S0140-6736(96)11380-5. [DOI] [PubMed] [Google Scholar]
  • 26.Bruneau J, Lamothe F, Franco E, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol. 1997;146:994–1002. doi: 10.1093/oxfordjournals.aje.a009240. [DOI] [PubMed] [Google Scholar]
  • 27.Centers for Disease Control and Prevention. Drug-associated HIV transmission continues in the United States. March 11, 2002. Available at: www.cdc.gov/hiv/pubs/facts/idu.htm. Accessed November 5, 2002.
  • 28.Purchase D. North American Syringe Exchange Network, personal communication, October 17, 2002.
  • 29.Gostin LO, Lazzarini Z, Jones TS, Flaherty K. Prevention of HIV/AIDS and other bloodborne diseases among injection drug users: a national survey on the regulation of syringes and needles. JAMA. 1997;277:53–62. doi: 10.1001/jama.277.1.53. [DOI] [PubMed] [Google Scholar]
  • 30.Friedman SR, Perlis T, Jarlais DC. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health. 2001;91:791–793. doi: 10.2105/ajph.91.5.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Bluthenthal RN, Kral AH, Lorvick J, Watters JK. Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Med Anthropol. 1997;18:61–83. doi: 10.1080/01459740.1997.9966150. [DOI] [PubMed] [Google Scholar]
  • 32.Kral AH, Lorvick J, Bluthenthal RN. Impact of drug paraphernalia laws in Bayview/Hunter’s Point. In: Proceedings of National Harm Reduction Conference; September 18–21, 1996; Oakland, CA.
  • 33.Bluthenthal RN, Kral AH, Erringer EA, Edlin BR. Drug paraphernalia laws and injection-related infectious disease risk among drug injectors. J Drug Issues. 1999;29:1–16. [Google Scholar]
  • 34.Jarlais DC, Breda MC. Haivaii Needle Exchange Program, 1996 Evaluation Report. Honolulu, HI: CHOW Project; 1997. [Google Scholar]
  • 35.Titus SP, Marmor M, Harrison C, Des Jarlais DC. Design of behavioral interventions for injection drug users: promoting needle exchange using cognitive-behavioral theory. In: Proceedings of 11th International Conference on AIDS; July 7–12, 1996; Vancouver, British Columbia, Canada.
  • 36.Rockwell R, Friedman SR, Sotheran JL, Perlis TE, Des Jarlais DC, Monterroso E. Proximity, needle exchange program use, and needle-related risk behavior among intrave
  • 37.California Assembly Bill No. 136 (1999).
  • 38.Kral AH, Anderson R, Clancey L, et al. California syringe exchange programs (SEPs) in 2000: operational characteristics, legal issues, and program needs. Oral presentation at: AIDS Research in California: Universitywide AIDS Research Programs Conference; February 22, 2002; Sacramento, CA.
  • 39.California Business and Professions Code S 4149.
  • 40.California Health and Safety Code S 11364 and 11364.7. [PubMed]
  • 41.Edlin BR, Lorvick J, Gann D, et al. Secondary syringe exchange providers as indigenous HIV prevention workers (session 4305). Oral presentation at: Abstracts of the 128th Annual Meeting of the American Public Health Association; November 12–16, 2000; Boston, MA.
  • 42.Valente TW, Foreman RK, Junge B, Vlahov D. Satellite exchange in the Baltimore needle exchange program. Public Health Rep. 1998;113:90–96. [PMC free article] [PubMed] [Google Scholar]
  • 43.Junge B, Valente R, Safaeian M, Brown M, Beilenson P, Vlahov D. From exchanger to non-exchanger: secondary acquisition of syringes given out by the Baltimore needle exchange program. Paper presented at: Twelfth World AIDS Conference; June 28-July 3, 1998; Geneva, Switzerland.
  • 44.Donoghoe MC, Dolan KA, Stimson GV. Life-style factors and social circumstances of syringe sharing in injecting drug users. Br J Addict. 1992;87:993–1003. doi: 10.1111/j.1360-0443.1992.tb03116.x. [DOI] [PubMed] [Google Scholar]
  • 45.Lorvick J, Edlin BR, Kral AH, et al. Secondary syringe exchange: how, for whom and why? Oral presentation at: Third National Harm Reduction Conference; October 21–25, 2000; Miami, FL.
  • 46.Downing M, Snead J, Lorvick J, et al. “I do it to save lives”: understanding how injection drug users operate their secondary syringe exchanges. Oral presentation at: AIDS Research in California: Universitywide AIDS Research Programs Conference; February 22, 2002; Sacramento, CA.
  • 47.Sears C, Guydish JR, Weltzien EK, Lum PJ. Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, USA. J Acquir Immune Defic Syndr. 2001;27:193–201. doi: 10.1097/00126334-200106010-00015. [DOI] [PubMed] [Google Scholar]
  • 48.Paone D, Clark J, Shi Q, Purchase D, Jarlais DC. Syringe exchange in the United States, 1996: a national profile. Am J Public Health. 1999;89:43–46. doi: 10.2105/ajph.89.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Zapka JG, Stoddard AM, McCusker J. Social network, support, and influence: relationships with drug use and protective AIDS behavior. AIDS Educ Prev. 1993;5:352–366. [PubMed] [Google Scholar]
  • 50.Abdul-Quader AS, Tross S, Friedman SR, Kouzi AC, Jarlais DC. Street-recruited intravenous drug use and sexual risk reduction in New York City. AIDS. 1990;4:1075–1079. doi: 10.1097/00002030-199011000-00004. [DOI] [PubMed] [Google Scholar]
  • 51.Magura S, Grossman JI, Lipton DS, et al. Determinants of needle sharing among intravenous drug users. Am J Public Health. 1989;79:459–462. doi: 10.2105/ajph.79.4.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Friedman SR, Jarlais DC, Sotheran JL, Garber J, Cohen H, Smith D. AIDS and selforganization among intravenous drug users. Int J Addict. 1987;22:201–219. doi: 10.3109/10826088709027425. [DOI] [PubMed] [Google Scholar]
  • 53.Jarlais DC, Friedman SR, Friedman P, et al. HIV/AIDS-related behavior change among injecting drug users in different national settings. AIDS. 1995;9:611–617. doi: 10.1097/00002030-199506000-00013. [DOI] [PubMed] [Google Scholar]
  • 54.Levy JA, Gallmeier CP, Weibel WW. The outreach assisted peer-support model for controlling drug dependency. J Drug Issues. 1995;25:507–529. [Google Scholar]
  • 55.Hawkins WE, Latkin C, Mandel W, Oziemkowska M. Do actions speak louder than words? Perceived peer influences on needle sharing and cleaning in a sample of injection drug users. AIDS Educ Prev. 1999;11:122–131. [PubMed] [Google Scholar]
  • 56.Broadhead RS, Heckathorn DD, Weakliem DL, et al. Harnessing peer networks as an instrument for AIDS prevention: results for a peer-driven intervention. Public Health Rep. 1998;113:42–57. [PMC free article] [PubMed] [Google Scholar]
  • 57.Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. People and places: behavioral settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr. 1996;13:273–280. doi: 10.1097/00042560-199611010-00010. [DOI] [PubMed] [Google Scholar]
  • 58.Wiebel WW. Combining ethnographic and epidemiologic methods in targeted AIDS interventions: the Chicago model. In: Battjes RJ, Pickens RW, editors. Needle Sharing Among Intravenous Drug Users. National and International Perspectives. Washington, DC: US Government Printing Office; 1988. pp. 137–150. [PubMed] [Google Scholar]
  • 59.Watters JK, Downing M, Case P. AIDS prevention for intravenous drug users in the community: street-based education and risk behavior. Am J Community Psychol. 1990;18:587–596. doi: 10.1007/BF00938061. [DOI] [PubMed] [Google Scholar]
  • 60.Booth RE, Wiebel WW. The effectiveness of reducing needle-related risks for HIV through indigenous outreach to injection drug users. Am J Addict. 1992;1:277–288. doi: 10.3109/10550499208993147. [DOI] [Google Scholar]
  • 61.Booth RE. Predictors of unsafe needle practices: injection drug users in Denver. J AIDS. 1994;7:504–508. [PubMed] [Google Scholar]
  • 62.Downing M, Knight KR, Vernon KA, et al. This is my story: a descriptive analysis of a peer education HIV/STD risk reduction program for women living in housing developments. AIDS Educ Prev. 1999;11:243–261. [PubMed] [Google Scholar]
  • 63.Latkin CA. Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Rep. 1998;113:151–159. [PMC free article] [PubMed] [Google Scholar]
  • 64.Kelly JA, St Lawrence JS, Diaz YE, et al. HIV risk behavior reduction following intervention with key opinion leaders of population: an experimental analysis. Am J Public Health. 1991;81:168–171. doi: 10.2105/ajph.81.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Kelly JA, Murphy DA, Sikkema KJ, et al. Randomized, controlled, community-level HIV prevention intervention for sexual-risk behavior among homosexual men in US cities. Lancet. 1997;350:1500–1505. doi: 10.1016/S0140-6736(97)07439-4. [DOI] [PubMed] [Google Scholar]
  • 66.Jarlais DC, Friedman SR. Shooting galleries and AIDS: infection probabilities and “tough” policies. Am J Public Health. 1990;80:142–145. doi: 10.2105/ajph.80.2.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Chitwood DD, McCoy CB, Inciardi DC, et al. HIV seropositivity of needles in shooting galleries in South Florida. Am J Public Health. 1990;80:150–152. doi: 10.2105/AJPH.80.2.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Carlson G, Needle R. Community-Based AIDS Prevention: Studies of Intravenous Drug Users and Their Sexual Partners. Proceeding of the First Annual NADR National Meeting. Washington, DC: US Government Printing Office; 1991. Sponsoring addict self-organization (addicts against AIDS): a case study. In: Department of Health and Human Services, National Institute on Drug Abuse, ed; pp. 342–349. [Google Scholar]
  • 69.Glaser B. Theoretical Sensitivity: Advances in the Methodology of Grounded Theory. Mill Valley, CA: Sociology Press; 1978. [Google Scholar]
  • 70.Strauss A, Corbin J. Basics of Qualitative Research: Grounded Theory Procedures and Techniques. Thousand Oaks, CA: Sage Publications; 1990. [Google Scholar]
  • 71.Carey JS, Wenzel PH, Reilly C, Sheridan J, Steinberg JM. CDC EZ-Text: software for management and analysis of semistructured qualitative data sets. Cult Anth Meth. 2001;10:14–20. [Google Scholar]
  • 72.Heimer R, Clair S, Grau LE, Bluthenthal RN, Marshall PA, Singer M. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction. 2002;97:1277–1287. doi: 10.1046/j.1360-0443.2002.t01-1-00211.x. [DOI] [PubMed] [Google Scholar]
  • 73.Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91:42–46. doi: 10.2105/ajph.91.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Hagan H, McGough JP, Thiede H, Weiss NS, Hopkins S, Alexander ER. Syringe exchange and risk of infection with hepatitis’B and C viruses. Am J Epidemiol. 1999;149:203–213. doi: 10.1093/oxfordjournals.aje.a009792. [DOI] [PubMed] [Google Scholar]
  • 75.Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 1999;94:675–683. doi: 10.1046/j.1360-0443.1999.9456755.x. [DOI] [PubMed] [Google Scholar]
  • 76.Flynn NM, Anderson R, Clancy L, Britton J. Seeing is believing: videotaped high-risk injection behavior. In: Seventh International Conference on the Reduction of Drug Related Harm; March 3–7, 1996; Hobart, Australia.
  • 77.Centers for Disease Control and Prevention Update: syringe exchange programs—United States, 1998. MMWR Morb Mortal Wkly Rep. 2001;50:384–387. [PubMed] [Google Scholar]
  • 78.New Attitudes and Strategies: a Comprehensive Approach to Preventing Blood-borne Infections Among IDUs. Atlanta, GA: Centers for Disease Control and Prevention; 2000. [Google Scholar]
  • 79.Weatherby N, Needle R, Cesari H, et al. Validity of self-reported drug use among injection drug users recruited through street outreach. Eval Prog Plann. 1994;17:347–355. doi: 10.1016/0149-7189(94)90035-3. [DOI] [Google Scholar]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES